PsoriasisView More Before & Afters
Psoriasis affects more than 5% of the population, yet is an often misunderstood skin condition. The scaly red patches may come and go, but the causes of psoriasis – a bothersome condition – can be anything ranging from heredity to a flare-up of another condition that allows psoriasis to happen.
Dr. Joel Schlessinger, a board-certified dermatologist at Schlessinger MD in Omaha, Nebraska can assess your skincare concerns and provide options for the treatment of psoriasis. Dr. Schlessinger has been involved in clinical research on psoriasis since 1997 and has worked to develop nearly every new psoriasis drug available, including Otezla, Humira, Enbrel, Skyrizi, Cosentyx and many others. He has the medical background to look at all aspects of this condition and work for solutions that will result in quick improvement.
My plaque psoriasis is 97% cleared up and I am so thankful. Extremely good care. Every employee is kind, compassionate and professional.
– Cinderella M.Read More Patient Reviews
Before & Afters
These are unretouched photos of Dr. Schlessinger’s own patients
What is psoriasis?
What causes psoriasis?
Relieving Your Skin From the Burden of Psoriasis?
‘I have been privileged to see the major changes in treatment options for psoriasis and been involved in the research on it. I love the changes that can be made in patients’ lives when the right treatment is initiated.’
Are you eligible to participate in a clinical trial to test a new treatment for psoriasis?
At the Schlessinger MD Skin Research Center located with Schlessinger MD in Omaha, Nebraska, Dr. Schlessinger and his clinical staff conduct research studies to test new medications for skin conditions.
He has conducted clinical research involving medications and treatments for psoriasis, and clinical studies are ongoing in the clinic on psoriasis. These innovative treatments are only available in a select group of clinics in the U.S. and available at no cost to study participants.
If you are eligible to participate in a clinical trial of new medications, Dr. Schlessinger can advise you when he sees you during an appointment.See Current Studies